Real-world treatment patterns and outcomes in patients with CLL and cardiovascular comorbidities: Interim analysis of the multicenter study conducted by eric.Thomas Chatzikonstantinou, Lydia Scarfò, Persefoni Talimtzi et al.|Blood|2025Cited by 0
Survival differences of patients with treatment-naive CLL between the chemoimmunotherapy and BTKi eras: An eric study.Thomas Chatzikonstantinou, Anna Puiggros, Persefoni Talimtzi et al.|Blood|2025Cited by 0
Treatability with ibrutinib plus venetoclax in patients with CLL in the real-world. the eric international thrive studyAndrea Visentin, Giuseppe Petruzzellis, Leonidas Benetatos et al.|Blood|2025Cited by 0